GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » Forward Dividend Yield %

United Laboratories International Holdings (FRA:UNJ) Forward Dividend Yield % : 5.01% (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings Forward Dividend Yield %?

As of today (2024-04-28), the Forward Annual Dividend Yield of United Laboratories International Holdings is 5.01%.

As of today (2024-04-28), the Trailing Annual Dividend Yield of United Laboratories International Holdings is 3.25%.

FRA:UNJ's Forward Dividend Yield % is ranked better than
84.65% of 495 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs FRA:UNJ: 5.01

United Laboratories International Holdings's Dividends per Share for the six months ended in Jun. 2023 was €0.02.

During the past 12 months, United Laboratories International Holdings's average Dividends Per Share Growth Rate was 49.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 29.90% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of United Laboratories International Holdings was 35.90% per year. The lowest was 7.90% per year. And the median was 29.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of United Laboratories International Holdings's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Forward Dividend Yield % falls into.



United Laboratories International Holdings Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

United Laboratories International Holdings Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.1312023-09-142023-09-182023-10-11Cash Dividendsemi-annuallyHKD:EUR 0.119669
HKD 0.1532023-07-042023-07-062023-07-26Cash Dividendsemi-annuallyHKD:EUR 0.115917

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

United Laboratories International Holdings's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.031353278/1.03
=3.04 %

Current Share Price is €1.03.
United Laboratories International Holdings's Dividends per Share for the forward twelve months is calculated as €0.015676639 * 2 = €0.031353278.

United Laboratories International Holdings's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.03341194/1.03
=3.24 %

Current Share Price is €1.03.
United Laboratories International Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.03341194.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings  (FRA:UNJ) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


United Laboratories International Holdings Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (FRA:UNJ) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines